TW200633715A - Medical combinations - Google Patents

Medical combinations

Info

Publication number
TW200633715A
TW200633715A TW094142714A TW94142714A TW200633715A TW 200633715 A TW200633715 A TW 200633715A TW 094142714 A TW094142714 A TW 094142714A TW 94142714 A TW94142714 A TW 94142714A TW 200633715 A TW200633715 A TW 200633715A
Authority
TW
Taiwan
Prior art keywords
medical combinations
medical
combinations
methods
receptor antagonists
Prior art date
Application number
TW094142714A
Other languages
Chinese (zh)
Inventor
Dramane Ibrahim Laine
Michael R Palovich
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of TW200633715A publication Critical patent/TW200633715A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
TW094142714A 2004-12-06 2005-12-05 Medical combinations TW200633715A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63361804P 2004-12-06 2004-12-06

Publications (1)

Publication Number Publication Date
TW200633715A true TW200633715A (en) 2006-10-01

Family

ID=36578468

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094142714A TW200633715A (en) 2004-12-06 2005-12-05 Medical combinations

Country Status (5)

Country Link
AR (1) AR052145A1 (en)
PE (1) PE20060826A1 (en)
TW (1) TW200633715A (en)
UY (1) UY29245A1 (en)
WO (1) WO2006062931A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050250A1 (en) 2003-07-17 2005-04-08 Glaxo Group Ltd ANTAGONISTS OF ACETYLCHOLIN MUSCARINAL RECEPTORS
TW200811172A (en) 2003-10-14 2008-03-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US7507747B2 (en) 2003-10-17 2009-03-24 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
AR046225A1 (en) 2003-11-04 2005-11-30 Glaxo Group Ltd COMPOSITE OF 8-AZONIABICICLO (3.2.1) OCTOBER, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES MEDIATED BY MUSCARINIC ACETILCOLINE RECEPTORS THAT UNDERSTAND IT AND USE OF THE COMPOUND TO PREPARE SUCH COMPOSITION
JP2007529513A (en) 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド M3 muscarinic acetylcholine receptor antagonist
UY28871A1 (en) 2004-04-27 2005-11-30 Glaxo Group Ltd ANTAGONISTS OF THE MUSCARINIC ACETILCOLINE RECEIVER
JP2007537261A (en) 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド Muscarinic acetylcholine receptor antagonist
WO2006055553A2 (en) 2004-11-15 2006-05-26 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
EP1937068A4 (en) 2005-08-18 2010-08-04 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
EP2080523A1 (en) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Compositions comprising an antimuscarinic and a long-acting beta-agonist
AR070564A1 (en) 2008-02-06 2010-04-21 Glaxo Group Ltd DERIVATIVES OF 1H-PIRAZOLO [3,4-B] PIRIDIN-5-ILO, PDE4 PHOSPHODIESTERASE INHIBITORS AND ACETILCOLINE MUSCARINIC RECEPTORS (MACHR) ANTAGONISTS, USEFUL IN THE TREATMENT AND / OR PROFILAXES AND PHYSPHOSITIZES, PHYSPHOSYSTEMS, AND PHARMOSES THAT UNDERSTAND THEM
PE20091552A1 (en) 2008-02-06 2009-10-25 Glaxo Group Ltd DUAL PHARMACOFOROS - PDE4 MUSCARINIC ANTAGONISTS
UY31636A1 (en) 2008-02-06 2009-08-03 DUE PHARMACOPHORES-MUSCARINIC ANTAGONISTS OF PDE4
DK2400950T3 (en) 2009-02-26 2019-07-29 Glaxo Group Ltd PHARMACEUTICAL FORMULA comprising 4 - {(1 R) -2 - [(6- {2 - [(2,6-DICHLORBENZYL) OXY] ETHOXY} HEXYL) AMINO] -1-HYDROXYETHYL} -2- (HYDROXYMETHYL) PHENOL
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
KR20140041699A (en) * 2011-06-08 2014-04-04 글락소 그룹 리미티드 Combination comprising umeclidinium and a corticosteroid
US9763965B2 (en) 2012-04-13 2017-09-19 Glaxosmithkline Intellectual Property Development Limited Aggregate particles
GB201222679D0 (en) 2012-12-17 2013-01-30 Glaxo Group Ltd Pharmaceutical combination products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1140998B (en) * 1980-06-18 1986-10-10 Valeas Ind Chimica E Farmaceut ENDO-8-METHYL-8-SIN-ALCHIL-8-AZONIABICYCLE OPEN SALTS PAR. SQUARE 3.2.1. CLOSED PAR. QUADRATA-OTTAN-3-ALCHILCARBOSSILATI, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE INGREDIENT
IT1194343B (en) * 1983-07-26 1988-09-14 Valeas Spa ENDO-8,8-DIALKYL-8-AZONIABICICLO SALTS (3.2.1) OTTAN-6,7-ESSO-EPOSSI-3-ALCHILCARBOSSILATI, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE INGREDIENT
DE19528145A1 (en) * 1995-08-01 1997-02-06 Boehringer Ingelheim Kg New drugs and their use
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases

Also Published As

Publication number Publication date
AR052145A1 (en) 2007-03-07
UY29245A1 (en) 2006-05-31
WO2006062931A3 (en) 2007-04-19
WO2006062931A2 (en) 2006-06-15
PE20060826A1 (en) 2006-10-08

Similar Documents

Publication Publication Date Title
TW200633715A (en) Medical combinations
MY144753A (en) Muscarinic acetylcholine receptor antagonists
TW200633706A (en) Medical combinations
MY143366A (en) Muscarinic acetylcholine receptor antagonists
TW200600093A (en) M3 muscarinic acetylcholine receptor antagonists
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
TW200600500A (en) M3 muscarinic acetylcholine receptor antagonists
WO2005067537A3 (en) Muscarinic acetylcholine receptor antagonists
WO2006065788A3 (en) Novel muscarinic acetylcholine receptor antagonists
WO2007022351A3 (en) Muscarinic acetylcholine receptor antagonists
WO2006050239A3 (en) Muscarinic acetylcholine receptor antagonists
WO2005112644A3 (en) Muscarinic acetylcholine receptor antagonists
WO2005046586A8 (en) M3 muscarinic acetylcholine receptor antagonists
WO2006055553A3 (en) Novel m3 muscarinic acetylcholine receptor antagonists
WO2006055503A3 (en) Novel m3 muscarinic acetylcholine receptor antagonists
WO2006005057A3 (en) Muscarinic acetylcholine receptor antagonists
WO2004012684A3 (en) M3muscarinic acetylcholine receptor antagonists
WO2007016650A3 (en) M3 muscarinic acetylcholine receptor antagonists
WO2007016639A3 (en) M3 muscarinic acetylcholine receptor antagonists
MXPA06000662A (en) Muscarinic acetylcholine receptor antagonists.
TW200519109A (en) Muscarinic acetylcholine receptor antagonists
WO2006017768A3 (en) Muscarinic acetylcholine receptor antagonists
ECSP066486A (en) MUSCARINIC ACETILCOLINE RECEIVER ANTAGONISTS II
TW200519108A (en) Muscarinic acetylcholine receptor antagonists
WO2005055941A3 (en) Novel m3 muscarinic acetylcholine receptor antagonists